Related Experiment Videos
Clonotypic heterogeneity in cutaneous T-cell lymphomas.
Y J Bignon1, P Souteyrand, H Roger
1Laboratoire d'Oncologie Moléculaire, Centre Jean Perrin, Clermont-Ferrand, France.
Cancer Research
|October 15, 1990
Summary
Clonotypic heterogeneity is common in cutaneous T-cell lymphomas, with 22% of cases showing diverse cell populations. This finding impacts understanding lymphoma evolution and diagnosis.
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- Antigen receptor genes, including immunoglobulin and T-cell receptor genes, are crucial for diagnosing lymphoid lineage clonality.
- Cutaneous T-cell lymphomas (CTCL) are a group of malignant diseases affecting the skin.
Purpose of the Study:
- To investigate the clonotypic heterogeneity in a cohort of 23 cutaneous T-cell lymphoma patients.
- To determine the frequency and implications of clonal heterogeneity in CTCL.
Main Methods:
- Clonotyping of immunoglobulin and T-cell receptor genes was performed on samples from 23 CTCL patients.
- Analyses included serial skin biopsies and different tumor samples from the same patient.
- Biopsies were analyzed over several months and from different tumor sites to assess heterogeneity.
Main Results:
- Five out of 23 CTCL cases (22%) exhibited clonotypic heterogeneity.
- Heterogeneity was particularly evident when analyzing different tumor sites or serial biopsies.
- One case presented a biophenotypic population with both immunoglobulin and T-cell receptor gene rearrangement.
Conclusions:
- A significant frequency of T-cell clonal heterogeneity was observed in cutaneous T-cell lymphomas.
- This heterogeneity may arise from subclone evolution or independent transformation events.
- Clonotypic heterogeneity in CTCL appears comparable to that found in B-cell leukemias.